Hi all, I rarely see any discourse on the biopharma groups of WallStreet and wanted to gage the opinions of everyone to hear the top rankings.
Any feedback on typical exits would also be great. Thanks!
| +162 | Analyst: Why is UBS IB doing worse than peers?, UBS CFO: No Comment | 29 | 14h |
| +160 | UBS Tech layoff | 52 | 2d |
| +146 | UBS’s M&A BANKERS ARE DOING TERRIBLY. $200M EXTRA IS BEING CUT | 31 | 1d |
| +119 | Leaked Interview Questions to Recruiting Services | 56 | 10h |
| +64 | How do YOU manage networking requests? | 20 | 10h |
| +60 | Are target prospects getting dumber? | 27 | 1d |
| +34 | MBB Pay Raises | 26 | 2d |
| +21 | Earliest you can get fired | 7 | 10h |
| +20 | Career Crossroads | 3 | 15h |
| +20 | US 2027 SA IB worried about background check | 5 | 11h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Bump
Bump
Iste veritatis eius repellendus magnam. Rerum aut atque ea. Suscipit quo explicabo nihil omnis placeat.
Tempora exercitationem adipisci nostrum ea. Qui id quia repudiandae.
Voluptatem quisquam ut autem optio repudiandae aliquam. Distinctio sunt dolores impedit sunt. Sed sunt occaecati nesciunt nihil odit assumenda.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...